ClinicalTrials.govpublic full text
Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
sickle cell disease, sickle cell anemia, hydroxyurea, nigeria, low income country, middle income country, developing country, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857518
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.